Skip to content

Immunogenicity of the third COVID-19 vaccine booster dose in adults with completed 2 doses as recommended by the ministry of public health

Immunogenicity of the third COVID-19 vaccine booster dose in adults with completed 2 doses as recommended by the ministry of public health

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20211120002
Enrollment
300
Registered
2021-11-20
Start date
2021-11-05
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Thai individuals aged 18 years and above immunogenicity, COVID-19. vaccine, booster

Interventions

Booster with AZD1222 in individuals vaccinated with two-dose BBIBP-CorV at 3-6 months post second vaccination.,Booster with BNT162b2 in individuals vaccinated with two-dose BBIBP-CorV.,Booster with mR
Booster with AZD1222 in individuals vaccinated with two-dose BBIBP-CorV,Booster with BNT162b2 in individuals vaccinated with two-dose BBIBP-CorV,Booster with mRNA-1273 in individuals vaccinated with t

Sponsors

National Research Council of Thailand (NRCT)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Healthy Thai individuals above 18 years of age 2. Not previously infected with COVID-19 3. Provide informed consent

Exclusion criteria

Exclusion criteria: 1. Previously infected with COVID-19 2. Immunocompromised individuals

Design outcomes

Primary

MeasureTime frame
immunogenicity day 14 and 28 post booster anti- receptor-binding domain of SARS-CoV-2

Secondary

MeasureTime frame
neutralizing activities against variants day 14 and 28 post booster sVNT,T cell response dat 14 and day 28 post boost Quantiferon SARS-CoV-2

Countries

Thailand

Contacts

Public ContactYong Poovorawan

Chulalongkorn University

yong.p@chula.ac.th022564000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026